Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Both large burns and severe gram-negative
sepsis
are associated with acute myocardial contractile dysfunction. Because others have reported that burn injury may be followed by transient endotoxemia, we hypothesized that bacterial endotoxin induces contractile impairment after burn trauma. We tested this hypothesis in two rodent models. In each model, postburn myocardial contractility was assessed using Langendorff preparations of excised hearts. In the first model, mice expressing either a mutant form of or no Toll-like receptor 4 (TLR4), a critical element of the mammalian endotoxin receptor, were resistant to postburn myocardial contractile dysfunction. In the second model, starting 30 min or 4 h after burn injury, rats were infused with recombinant bactericidal/permeability-increasing protein (
rBPI
(21)), a protein that binds and neutralizes endotoxin. Hearts from
rBPI
(21)-treated animals were completely protected from postburn contractile impairment. Because burn-induced contractile dysfunction can be prevented either by blocking signaling through the endotoxin receptor or by neutralizing circulating LPS, bacterial endotoxin may contribute to impaired myocardial contractility after burn injury.
...
PMID:TLR4 inactivation and rBPI(21) block burn-induced myocardial contractile dysfunction. 1223 19
Antimicrobial peptides are important components of host defenses against microbial invasions.
Bactericidal permeability-increasing protein
(
BPI
) is an antimicrobial peptide belonging to the lipid transfer/LPS-binding protein family. It serves important roles in defending against Gram-negative bacteria in the innate immune system. Here we report cloning of complete
BPI
cDNA from channel catfish (Ictalurus punctatus) by 5' RACE after obtaining the partial
BPI
cDNA sequence from EST analysis. The channel catfish
BPI
cDNA is 1640 bp in length with a 1428-bp open reading frame that encodes a protein of 475 amino acids. Catfish
BPI
gene shows high similarity with the
BPI
/LBP gene isolated from other teleost fish. As part of ongoing efforts in comparative genome analysis, we have assigned the catfish
BPI
gene to bacterial artificial chromosome (BAC) clones. Southern blot analysis on multiple
BPI
BAC clones indicated the presence of a single copy of the
BPI
gene in the catfish genome. Reverse transcription-polymerase chain reaction (RT-PCR) analysis on healthy tissues showed that
BPI
was expressed in a wide range of tissues including head kidney, gill, skin, trunk kidney, brain, intestine, liver, muscle, ovary, spleen and stomach. The
BPI
gene was not developmentally expressed until 48 h after fertilization. Quantitative real time PCR (QRT-PCR) analysis indicated that the
BPI
gene expression was induced after challenge with Edwardsiella ictaluri, the causative agent of enteric
septicemia
of catfish (ESC).
BPI
upregulation peaked 3 days after challenge, mirroring the expression pattern of inflammatory chemokines in catfish, suggesting that it plays a role in the innate defense response.
...
PMID:Characterization and expression analysis of bactericidal permeability-increasing protein (BPI) antimicrobial peptide gene from channel catfish Ictalurus punctatus. 1589 43
rBPI
(23) is a recombinant protein based upon the N-terminal sequence of bactericidal permeability increasing protein (BPI), a protein present in the granules of polymorphonuclear leukocytes. BPI has antibacterial activity against Gram-negative organisms and potent endotoxin neutralising properties.
rBPI
(23) has been developed as a potential agent for use in Gram-negative
sepsis
and has completed phase 1 clinical trials. In this study a broth microdilution chequerboard method has been used to investigate the interaction between
rBPI
(23) and gentamicin, an antibiotic used in a similar clinical setting. Using organisms with a range of inherent susceptibilities to
rBPI
(23), additive or synergistic effects were seen which tended to be proportional to the sensitivity to
rBPI
(23) alone.
...
PMID:A study of the interaction between recombinant bactericidal permeability increasing protein (rBPI(23)) and gentamicin. 1861 77
Septic or endotoxic shock is a common cause of death in hospital intensive care units. In the last decade numerous antimicrobial peptides and proteins have been tested in the search for an efficient drug to treat this lethal disease. Now in phase III clinical trials,
rBPI
(21), a recombinant N-terminal fragment of the bactericidal/permeability-increasing protein (BPI), is a promising drug to reduce lesions caused by meningococcal
sepsis
. We correlated structural and stability data with functional information of
rBPI
(21) bound to both model systems of eukaryotic and bacterial membranes. On interaction with membranes,
rBPI
(21) loses its conformational stability, as studied by circular dichroism. This interaction of
rBPI
(21) at membrane level was higher in the presence of negatively charged phospholipid relatively to neutral ones, with higher partition coefficients (K(p)), suggesting a preference for bacterial membranes over mammalian membranes.
rBPI
(21) binding to membranes is reinforced when its disulfide bond is broken due to conformational changes of the protein. This interaction is followed by liposome aggregation due to unfolding, which ensures protein aggregation, and interfacial localization of
rBPI
(21) in membranes, as studied by extensive quenching by acrylamide and 5-deoxylstearic acid and not by 16-deoxylstearic acid. An uncommon model of the selectivity and mechanism of action is proposed, where membrane induces unfolding of the antimicrobial protein,
rBPI
(21). The unfolding ensures protein aggregation, established by protein-protein interaction at membrane surface or between adjacent membranes covered by the unfolded protein. This protein aggregation step may lead to membrane perturbation.
...
PMID:Fold-unfold transitions in the selectivity and mechanism of action of the N-terminal fragment of the bactericidal/permeability-increasing protein (rBPI(21)). 1918 36